Provided by Tiger Trade Technology Pte. Ltd.

Janux Therapeutics, Inc.

17.39
+0.11000.64%
Post-market: 17.450.0600+0.35%19:30 EDT
Volume:520.04K
Turnover:9.06M
Market Cap:1.06B
PE:-10.58
High:17.70
Open:17.40
Low:17.21
Close:17.28
52wk High:35.34
52wk Low:12.12
Shares:61.14M
Float Shares:49.82M
Volume Ratio:0.72
T/O Rate:1.04%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6429
EPS(LYR):-1.8336
ROE:-10.70%
ROA:-8.80%
PB:1.15
PE(LYR):-9.48

Loading ...

Janus Living Prices Share Offering

MT Newswires Live
·
Aug 11

RBC Adjusts Price Target on Janux Therapeutics to $34 From $30, Maintains Outperform Rating

MT Newswires Live
·
Aug 10

Analysts Offer Insights on Healthcare Companies: Oric Pharmaceuticals (ORIC), Janux Therapeutics Inc (JANX) and Entrada Therapeutics Inc (TRDA)

TIPRANKS
·
Aug 10

Analyst Maintains Buy on Janux Therapeutics, Keeps $60 Price Target Unchanged on Strong Balance Sheet and Clinical Differentiation

TIPRANKS
·
Aug 08

Janux Therapeutics is Maintained at Buy by Guggenheim

Dow Jones
·
Aug 08

Janux Therapeutics price target lowered to $55 from $58 at Guggenheim

TIPRANKS
·
Aug 07

Janux Therapeutics Inc (JANX) Receives a Sell from Barclays

TIPRANKS
·
Aug 07

Analysts’ Top Healthcare Picks: Lyell Immunopharma (LYEL), Janux Therapeutics Inc (JANX)

TIPRANKS
·
Aug 07

Janux Therapeutics Q2 EPS $(0.35) Beats $(0.38) Estimate, Sales $10.267M Miss $16.493M Estimate

Benzinga Earnings
·
Aug 07

Janux Therapeutics, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 07

Janux Therapeutics reports Q2 EPS (35c), consensus (29c)

TIPRANKS
·
Aug 07

Janux Therapeutics Q2 Basic EPS USD -0.35

THOMSON REUTERS
·
Aug 07

Janux Therapeutics Coverage Assumed by Truist Securities at Buy

Dow Jones
·
Jun 25

Analysts Offer Insights on Healthcare Companies: Sionna Therapeutics, Inc. (SION) and Janux Therapeutics Inc (JANX)

TIPRANKS
·
Jun 25

U.S. Research Roundup-caseys General Stores, Micron Technology, SAP

Reuters
·
Jun 25

Janux Therapeutics reports departure of Chief Medical Officer

TIPRANKS
·
Jun 24

Janux Therapeutics CMO William Go departs under severance plan terms

Reuters
·
Jun 24

Janux Therapeutics Reports Results of 2026 Annual Meeting

TIPRANKS
·
Jun 13

Janux Therapeutics shareholders elect two directors at annual meeting

Reuters
·
Jun 13

Janux VP Accounting Maria Dobek sells 2,038 shares worth $28,874.46

Reuters
·
May 14